BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wrigley R, Phipps-Green AJ, Topless RK, Major TJ, Cadzow M, Riches P, Tausche AK, Janssen M, Joosten LAB, Jansen TL, So A, Harré Hindmarsh J, Stamp LK, Dalbeth N, Merriman TR. Pleiotropic effect of the ABCG2 gene in gout: involvement in serum urate levels and progression from hyperuricemia to gout. Arthritis Res Ther 2020;22:45. [PMID: 32164793 DOI: 10.1186/s13075-020-2136-z] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Wang Z, Li Y, Liao W, Huang J, Liu Y, Li Z, Tang J. Gut microbiota remodeling: A promising therapeutic strategy to confront hyperuricemia and gout. Front Cell Infect Microbiol 2022;12:935723. [DOI: 10.3389/fcimb.2022.935723] [Reference Citation Analysis]
2 Copur S, Demiray A, Kanbay M. Uric acid in metabolic syndrome: Does uric acid have a definitive role? European Journal of Internal Medicine 2022. [DOI: 10.1016/j.ejim.2022.04.022] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Russell EM, Carlson JC, Krishnan M, Hawley NL, Sun G, Cheng H, Naseri T, Reupena MS, Viali S, Tuitele J, Major TJ, Miljkovic I, Merriman TR, Deka R, Weeks DE, McGarvey ST, Minster RL. CREBRF missense variant rs373863828 has both direct and indirect effects on type 2 diabetes and fasting glucose in Polynesian peoples living in Samoa and Aotearoa New Zealand. BMJ Open Diabetes Res Care 2022;10:e002275. [PMID: 35144939 DOI: 10.1136/bmjdrc-2021-002275] [Reference Citation Analysis]
4 Sivera F, Andres M, Dalbeth N. A glance into the future of gout. Therapeutic Advances in Musculoskeletal 2022;14:1759720X2211140. [DOI: 10.1177/1759720x221114098] [Reference Citation Analysis]
5 Vargas-Morales JM, Guevara-Cruz M, Aradillas-García C, G Noriega L, Tovar A, Alegría-Torres JA. Polymorphisms of the genes ABCG2, SLC22A12 and XDH and their relation with hyperuricemia and hypercholesterolemia in Mexican young adults. F1000Res 2021;10:217. [PMID: 34631016 DOI: 10.12688/f1000research.46399.2] [Reference Citation Analysis]
6 Kukal S, Guin D, Rawat C, Bora S, Mishra MK, Sharma P, Paul PR, Kanojia N, Grewal GK, Kukreti S, Saso L, Kukreti R. Multidrug efflux transporter ABCG2: expression and regulation. Cell Mol Life Sci 2021;78:6887-939. [PMID: 34586444 DOI: 10.1007/s00018-021-03901-y] [Reference Citation Analysis]
7 Nelson KL, Voruganti VS. Purine metabolites and complex diseases: role of genes and nutrients. Curr Opin Clin Nutr Metab Care 2021;24:296-302. [PMID: 33928921 DOI: 10.1097/MCO.0000000000000764] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
8 Sandoval-Plata G, Morgan K, Abhishek A. Variants in urate transporters, ADH1B, GCKR and MEPE genes associate with transition from asymptomatic hyperuricaemia to gout: results of the first gout versus asymptomatic hyperuricaemia GWAS in Caucasians using data from the UK Biobank. Ann Rheum Dis 2021;80:1220-6. [PMID: 33832965 DOI: 10.1136/annrheumdis-2020-219796] [Cited by in Crossref: 1] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
9 Butler F, Alghubayshi A, Roman Y. The Epidemiology and Genetics of Hyperuricemia and Gout across Major Racial Groups: A Literature Review and Population Genetics Secondary Database Analysis. J Pers Med 2021;11:231. [PMID: 33810064 DOI: 10.3390/jpm11030231] [Cited by in Crossref: 3] [Cited by in F6Publishing: 21] [Article Influence: 3.0] [Reference Citation Analysis]
10 Takei R, Cadzow M, Markie D, Bixley M, Phipps-Green A, Major TJ, Li C, Choi HK, Li Z, Hu H, Guo H, He M, Shi Y, Stamp LK, Dalbeth N, Merriman TR, Wei WH; Eurogout Consortium. Trans-ancestral dissection of urate- and gout-associated major loci SLC2A9 and ABCG2 reveals primate-specific regulatory effects. J Hum Genet 2021;66:161-9. [PMID: 32778763 DOI: 10.1038/s10038-020-0821-z] [Cited by in F6Publishing: 1] [Reference Citation Analysis]